-
Mashup Score: 2Fewer than half of new drugs add substantial therapeutic value over existing treatments, study finds - 10 month(s) ago
New drugs are often used not only for one disease (first approved indication) but also for other diseases (supplemental indications).
Source: medicalxpress.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 2As big pharma loses interest in new antibiotics, infections are only growing stronger - 2 year(s) ago
Existing drugs still treat most infections. But that has discouraged investment in new drugs that will be needed when — not if —the old ones fail.
Source: Modern HealthcareCategories: General Medicine News, Latest HeadlinesTweet-
Existing drugs still treat most #infections. But that has discouraged #investment in #newdrugs that will be needed when — not if —the old ones fail. #antibiotics https://t.co/t8HBfFdkxi
-
-
Mashup Score: 0ATS 2022 International Conference | Session - 2 year(s) ago
AMERICAN THORACIC SOCIETY 25 Broadway New York, NY 10004 United States of America Phone: +1 (212) 315-8600 Email: conference@thoracic.org Conference Registration cOASIS Technical Support | Monday – Friday, 9 am – 5 pm CT | Phone: 217-398-1792 | Email: cOASIS Helpdesk Powered by cOASIS, The Online Abstract Submission and Invitation System SM © 1996 -…
Source: www.abstractsonline.comCategories: Latest Headlines, PulmonologyTweet-
Interested in developing #newdrugs/technologies and commercialization for #discoveries made in academia? Register for PG6 course at #ATS2022 : https://t.co/JnlkvagDRi topics:start-up formation, IP, drug development, IND-enabling studies, funding, business development and more https://t.co/CtjQQYvIhP
-
-
Mashup Score: 9
Structural biologists at St. Jude Children’s Research Hospital have determined the detailed structure of an enzyme whose mutated forms are known to cause Parkinson’s disease. The achievement opens a research pathway to develop new drugs that can specifically target the aberrant form of a protein enzyme called LRRK2.
Source: medicalxpress.comCategories: General Medicine News, Latest HeadlinesTweet-
#Structure of enzyme that causes Parkinson's promises pathways to #newdrugs @CellCellPress https://t.co/dqYrIw5FE7
-
-
Mashup Score: 5New drugs to fight COVID-19 developed - 3 year(s) ago
Scientists from QIMR Berghofer Medical Research Institute in Queensland have developed two new drugs to both prevent SARS-CoV-2 infection, and also treat people who have been exposed to the virus so they do not develop severe disease.
Source: medicalxpress.comCategories: General Medicine News, Latest HeadlinesTweet-
#Newdrugs to fight COVID-19 developed https://t.co/R7rvSpLp5w
-
-
Mashup Score: 0FORUM Science & Health 2021 - 3 year(s) ago
Jeanne Turczynski, Medizin-Redakteurin des Bayerischen Rundfunks, diskutiert in unserem #1 Livestream mit unseren ExpertInnen um die Frage, ob der beschleunigte Zulassungsprozess wie gerade bei den Covid19-Impfstoffen eine Blaupause für zukünftige Wirkstoff-Zulassungen sein kann. Oder geht hier Schnelligkeit auf Kosten der Sicherheit? Wie kann man die Balance halten und dennoch…
Source: FORUM Science & HealthCategories: Future of Medicine, Latest HeadlinesTweet-
ITM and BioM partners again! We are pleased to sponsor a series of informative webinars named “FORUM Science & Health” hosted by @BioM_Munich, the Munich #biotech cluster. Don’t miss the discussion on February 12, regarding the approval of #NewDrugs. https://t.co/ZPjXDZH3pq https://t.co/skqQI83Etv
-
-
Mashup Score: 0FORUM Science & Health 2021 - 3 year(s) ago
Jeanne Turczynski, Medizin-Redakteurin des Bayerischen Rundfunks, diskutiert in unserem #1 Livestream mit unseren ExpertInnen um die Frage, ob der beschleunigte Zulassungsprozess wie gerade bei den Covid19-Impfstoffen eine Blaupause für zukünftige Wirkstoff-Zulassungen sein kann. Oder geht hier Schnelligkeit auf Kosten der Sicherheit? Wie kann man die Balance halten und dennoch…
Source: FORUM Science & HealthCategories: Future of Medicine, Latest HeadlinesTweet-
ITM and BioM partners again! We are pleased to sponsor a series of informative webinars named “FORUM Science & Health” hosted by @BioM_Munich , the Munich #biotech cluster. Don’t miss the discussion on February 12, regarding the approval of #NewDrugs. https://t.co/ZPjXDZH3pq https://t.co/OP2ez6ulpT
-
-
Mashup Score: 1Dermatology Times - 4 year(s) ago
Melasma responds well to oral and locally injected tranexamic acid treatments, but clinical results from topical tranexamic acid administration have been disappointing, researchers report. They examined efficacy of a co-enhancer as a method to deliver the treatment.
Source: Dermatology TimesCategories: DermatologyTweet-
Dressed as Carnac the Magnificent to present on 2020s #newdrugs and #treatments, Dr.’s Bhatia and Rosen say, “[It’s] different than usual medical meeting talk, that's for darn sure.” https://t.co/ghnQp7LnX8. Stay tuned for more onsite coverage of the current @MauiDerm https://t.co/LRIg9yueI2
-
Fewer than half of #newdrugs add substantial therapeutic value over existing treatments, study finds @bmj_latest https://t.co/ek3s5acidC